rs386134256
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
|
22723327 |
2012 |
rs386134256
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Guidelines for diagnosis and therapy of MEN type 1 and type 2.
|
11739416 |
2001 |
rs386134256
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
rs386134256
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
|
15604628 |
2004 |
rs386134256
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
|
20065170 |
2010 |
rs386134256
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs386134256
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs386134256
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).
|
26224587 |
2016 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
MEN1 gene mutations in 12 MEN1 families and their associated tumors.
|
9820618 |
1998 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
Clinical Features and Response to Treatment of Prolactinomas in Children and Adolescents: A Retrospective Single-Centre Analysis and Review of the Literature.
|
29455199 |
2018 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1.
|
11578300 |
2001 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours.
|
24443791 |
2014 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening.
|
17235589 |
2007 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value.
|
19350320 |
2009 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary?
|
28321559 |
2017 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
|
25824098 |
2015 |
rs386134256
|
|
G |
0.800 |
CausalMutation |
CLINVAR |
Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.
|
17853334 |
2007 |